Jiangxi Fushine Pharmaceutical Co Ltd (300497) — Financial Flexibility Index
Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥61.36 Million (operating CF CN¥18.31 Million minus capex CN¥43.04 Million) represents 0% of total liabilities (CN¥2.27 Billion). Check 300497 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangxi Fushine Pharmaceutical Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Jiangxi Fushine Pharmaceutical Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see Jiangxi Fushine Pharmaceutical Co Ltd (300497) cash flow conversion.
Annual Financial Flexibility Index for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Jiangxi Fushine Pharmaceutical Co Ltd. Explore Jiangxi Fushine Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥287.56 Million | CN¥62.67 Million | CN¥2.20 Billion | ▼ -6.5% |
| 2024 | 0.14x | CN¥329.39 Million | CN¥187.64 Million | CN¥2.36 Billion | ▲ +84.7% |
| 2023 | 0.08x | CN¥177.46 Million | CN¥-64.76 Million | CN¥2.35 Billion | ▼ -47.1% |
| 2022 | 0.14x | CN¥338.56 Million | CN¥-120.85 Million | CN¥2.37 Billion | ▼ -66.4% |
| 2021 | 0.43x | CN¥751.92 Million | CN¥72.32 Million | CN¥1.77 Billion | ▼ -48.9% |
| 2020 | 0.83x | CN¥831.59 Million | CN¥382.35 Million | CN¥997.93 Million | ▲ +34.3% |
| 2019 | 0.62x | CN¥662.81 Million | CN¥337.91 Million | CN¥1.07 Billion | ▲ +91.7% |
| 2018 | 0.32x | CN¥339.80 Million | CN¥175.91 Million | CN¥1.05 Billion | ▼ -14.0% |
| 2017 | 0.38x | CN¥309.72 Million | CN¥210.72 Million | CN¥822.70 Million | ▼ -14.3% |
| 2016 | 0.44x | CN¥269.87 Million | CN¥188.53 Million | CN¥614.20 Million | ▲ +22.9% |
| 2015 | 0.36x | CN¥147.75 Million | CN¥74.01 Million | CN¥413.44 Million | ▲ +49.9% |
| 2014 | 0.24x | CN¥83.25 Million | CN¥31.39 Million | CN¥349.09 Million | ▼ -44.1% |
| 2013 | 0.43x | CN¥132.82 Million | CN¥57.22 Million | CN¥311.55 Million | ▲ +8.7% |
| 2012 | 0.39x | CN¥114.44 Million | CN¥63.20 Million | CN¥291.70 Million | ▼ -21.5% |
| 2011 | 0.50x | CN¥116.01 Million | CN¥33.80 Million | CN¥232.04 Million | — |